Brief From our Editor -- BioNTech SE (BNTX) Stock.

Shares of BioNTech SE have moved -4.2% today, and are now trading at a price of $147.2. In contrast, the S&P 500 index saw a 0.6% change. Today's trading volume is 362,772 compared to the stock's average volume of 972,777.

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Based in Mainz, Germany the company has 3,082 full time employees and a market cap of $35,699,421,184.

The company is now trading -34.26% away from its average analyst target price of $223.91 per share. The 14 analysts following the stock have set target prices ranging from $149.47 to $314.09, and on average give BioNTech SE a rating of buy.

A string of strong margins growth bodes well for the company's future:

Date Reported Revenue ($ MM) Cost of Revenue ($ MM) Gross Margins (%) YoY Growth (%)
2021-12-31 18,977 3,861 79.66 273.06
2020-12-31 482 704 -46.03 63.04
2019-12-31 109 244 -124.54 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.